Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +47.56%
#3 Cysic Cysic +41.67%
#4 Glidr Glidr +36.41%
#5 Walrus Walrus +29.37%
#6 Humanity Humanity +23.38%
#7 Codatta Codatta +16.38%
#8 Enso Enso +16.32%
#9 Tutorial Tutorial +15.81%
#10 Ribbita by Virtuals Ribbita by Virtuals +14.43%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Classificação em ações #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Preço da ação
$0.6
Última sincronização: 2024-08-14
Valor de mercado
$2.09M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
SG
Negociar ASLAN Pharmaceuticals Limited (ASLN)

Categoria

Healthcare
Rácio P/S de ASLAN Pharmaceuticals Limited (ASLN)
Rácio P/S em August 2026 TTM: 64.76
De acordo com os relatórios financeiros mais recentes e o preço das ações da ASLAN Pharmaceuticals Limited, o rácio P/S atual (TTM) é 64.76. No final de 2022, o rácio P/S era 0.00.
Histórico do rácio P/S da ASLAN Pharmaceuticals Limited de 2014 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
2026 (TTM) 64.76 28,056.61%
2023 0.23 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 7.03 0.00%
2018 0.00 0.00%
2017 0.00 -100.00%
2016 4.07 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -84.30%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -84.36%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -92.68%
BE